Save your place

Sign in to WhoBought

Please try again later.

Legend Biotech Corporation (LEGN) institutional ownership

Latest close $18.55 Jul 31, 2026
Market cap$3.6B 52-week range SectorHealthcare
Funds holding · Q1 2026
197
reported LEGN position changes
Top owners · Q2 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
108 buyers · 89 sellers

Legend Biotech Corporation (LEGN) price and institutional activity

Dates

Q1 2026

$0 bought by 108 investors
First Beijing Investment LtdDeerfield Management Company, L.P. +106 more
$0 sold by 89 investors
Alliancebernstein L.P.Braidwell LP +87 more
Bought Sold Totals per quarter; hover a bar for the names.

Legend Biotech Corporation (LEGN) institutional activity · 108

Investor Type Est. change Change Δ Own Date
First Beijing Investment Ltd · New
Change +2.3M Date Q1 2026
First Beijing Investment Ltd New· Q1 2026 +2.3M Q1 2026
Deerfield Management Company, L.P. · Added
Change +1.8M Date Q1 2026
Deerfield Management Company, L.P. Added· Q1 2026 +1.8M Q1 2026
Kynam Capital Management, LP · New
Change +1.6M Date Q1 2026
Kynam Capital Management, LP New· Q1 2026 +1.6M Q1 2026
FMR LLC · Added
Change +1.4M Δ Own +5.9% Date Q1 2026
FMR LLC Added· Q1 2026 +1.4M +5.9% Q1 2026
Two Sigma Investments, LP · Added
Change +1.4M Δ Own +259.3% Date Q1 2026
Two Sigma Investments, LP Added· Q1 2026 +1.4M +259.3% Q1 2026
Point72 Asset Management, L.P. · Added
Change +1.1M Δ Own +39.5% Date Q1 2026
Point72 Asset Management, L.P. Added· Q1 2026 +1.1M +39.5% Q1 2026
Patient Square Capital LP · New
Change +990K Date Q1 2026
Patient Square Capital LP New· Q1 2026 +990K Q1 2026
Suvretta Capital Management, LLC · Added
Change +972K Date Q1 2026
Suvretta Capital Management, LLC Added· Q1 2026 +972K Q1 2026
Acadian Asset Management LLC · Added
Change +945K Date Q1 2026
Acadian Asset Management LLC Added· Q1 2026 +945K Q1 2026
BlackRock · Added
Change +408K Date Q1 2026
BlackRock Added· Q1 2026 +408K Q1 2026
Triata Capital Ltd · Added
Change +377K Date Q1 2026
Triata Capital Ltd Added· Q1 2026 +377K Q1 2026
Citadel Advisors LLC Added· Q1 2026 +339K +190.4% Q1 2026
Arrowstreet Capital, Limited Partnership · Added
Change +315K Date Q1 2026
Arrowstreet Capital, Limited Partnership Added· Q1 2026 +315K Q1 2026
Hudson Bay Capital Management LP · Added
Change +301K Date Q1 2026
Hudson Bay Capital Management LP Added· Q1 2026 +301K Q1 2026
Davern Capital Partners, LP · Added
Change +258K Date Q1 2026
Davern Capital Partners, LP Added· Q1 2026 +258K Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
15 of 108

Famous investor activity in Legend Biotech Corporation (LEGN)

Legend Biotech Corporation (LEGN) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Casey Patrick John · Director Sell −$89K
Price $14.80 Qty −6K Owned 49K ΔOwn −11.0% Trade date Jun 30, 2026 Filed date Jul 2, 2026
Casey Patrick John Director Sell $14.80 −6K −$89K 49K −11.0% Jun 30, 2026 Jul 2, 2026
Huang Ying · Director Gift (G) -3K
Owned 238K ΔOwn −1.4% Trade date Jun 30, 2026 Filed date Jul 2, 2026
Huang Ying Director Gift (G) -3K 238K −1.4% Jun 30, 2026 Jul 2, 2026
Huang Ying · Director Sell −$82K
Price $14.78 Qty −6K Owned 242K ΔOwn −2.2% Trade date Jun 25, 2026 Filed date Jun 29, 2026
Huang Ying Director Sell $14.78 −6K −$82K 242K −2.2% Jun 25, 2026 Jun 29, 2026
Huang Ying · Director, Officer Sell −$87K
Price $8.77 Qty −10K Owned 247K Trade date Mar 25, 2026 Filed date Mar 27, 2026
Huang Ying Director, Officer Sell $8.77 −10K −$87K 247K Mar 25, 2026 Mar 27, 2026
4 of 4

Legend Biotech Corporation (LEGN) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Genscript Biotech Corp 174.5M
% of shares outstanding 48.0% Filing date Feb 14, 2024
Genscript Biotech Corp 174.5M 48.0% Feb 14, 2024
FMR LLC 36.4M
% of shares outstanding 10.0% Filing date Nov 12, 2024
FMR LLC 36.4M 10.0% Nov 12, 2024
T. Rowe Price Associates 11.1M
% of shares outstanding 6.1% Filing date Nov 14, 2024
T. Rowe Price Associates 11.1M 6.1% Nov 14, 2024
Hillhouse Investment Management, Ltd. 13.1M
% of shares outstanding 3.6% Filing date Feb 14, 2024
Hillhouse Investment Management, Ltd. 13.1M 3.6% Feb 14, 2024
BlackRock Inc. 10.8M
% of shares outstanding 3.0% Filing date Apr 5, 2024
BlackRock Inc. 10.8M 3.0% Apr 5, 2024
Zhang Fangliang 1.1M
% of shares outstanding 0.3% Filing date Feb 14, 2023
Zhang Fangliang 1.1M 0.3% Feb 14, 2023
Aquapoint L.P. 407K
% of shares outstanding 0.0% Filing date Feb 14, 2023
Aquapoint L.P. 407K 0.0% Feb 14, 2023
7 of 7

Legend Biotech Corporation (LEGN) ownership FAQ

Who owns LEGN?

197 reporting institutions disclosed LEGN position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.